DocumentsDate added
Review article
Milad Moloudizargari1,*, Shahin Aghajanshakeri1, Soheil Javaherypour1,
Mona Escort1, Salar Velzi2, Sina Velzi2
Affiliation:-
1Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
2Faculty of Veterinary Medicine, Islamic Azad University of Urmia, Iran
The name of the department(s) and institution(s) to which the work should be attributed:
1.Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
2.Faculty of Veterinary Medicine, Islamic Azad University of Urmia, Iran
*To whom it corresponds:-
Milad Moloudizargari.
Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
Email: miladmoludi@gmail.com
Abstract
Yarrow (Achillea millefolium L. family Asteraceae) is a well-known medicinal plant in Iran and various parts of this plant including its flowers have been long used in traditional folk medicine of several cultures, from Europe to Asia. This plant contains a large amount of bioactive compounds that are contributed to a wide range of medicinal properties. Research has revealed different pharmacological and therapeutic effects of A. millefolium and its glycol-alkaloids (particularly achilleine). Studies carried out on the chemical composition of the plant show that the most important constituents of this plant are chamazulene, camphor, sesquiterpene lactones and caryophyllene. In addition to A. millefolium (Asteraceae) achilleine is present in many other plants and is used for the treatment of different diseases. This article reviews the traditional uses and pharmacological effects of total extract and the most active substances of A. millefolium.
Keywords: Achillea millefolium; Yarrow; Achilleine; Pharmacological effects.
Article citation:
Moloudizargari M, Aghajanshakeri S, Javaherypour Soheil, Escort M, Velzi Salar, Velzi Sina. A current update on the phytopharmacological aspects of Achillea millefolium. J Pharm Biomed Sci 2014; 04(04):310-317. Available at www.jpbms.info.
REFERENCES
1.Akkol K E, Koca U, Pesin I, Yilmazar D. Evaluation of theWound Healing Potential of AchilleabiebersteiniiAfan. (Asteraceae) by In Vivo Excision and Incision Models.Hindawi Publishing Corporation, Evidence-Based omplementary and Alternative Medicine. 2011; Article ID 474026, 7 pages.
2.Applequist W.L., Moerman, D.E. Yarrow (Achilleamillefolium L.): a neglected panacea? A review of ethnobotany, bioactivity, and biomedical research.Eco-nomic Botany. 2011; 65: 209–225.
3.Baggio C, Freitas C, Nhaducue P, Rieck L, Marques M. Action of crude aqueous extract of leaves of Achillea millefolium L.(Compositae) on gastrointestinal tract. Rev. Bras. 2002; Farmacogn., v. 12, supl., p. 31-33.
4.Bardhan P, Sharma SK, Garg NK. In vitro effect of an Ayurvedic liver remedy on hepatic enzymes in carbon tetrachloride treated rats. The Indian journal of medical research 1985; 82: 359-64.
5.Baretta IP, Felizardo RA, Bimbato VF, dos Santos MG, Kassuya CA, Gasparotto Junior A. Anxiolytic-like effects of acute and chronic treatment with Achillea millefolium L. extract. Journal of ethnopharmacology 2012;140 (1): 46-54.
6.Benedek B, Geisz N, Jager W, Thalhammer T, Kopp B. Choleretic effects of yarrow (Achilleamillefoliums.l.) in the isolated perfused rat liver. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2006; 13(9-10): 702-6.
7.De Souza P, Gasparotto A, Jr., Crestani S, Stefanello ME, Marques MC, da Silva-Santos JE. Hypotensive mechanism of the extracts and artemetin isolated from Achillea millefolium L. (Asteraceae) in rats. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2011; 18 (10): 819-25.
8.Duarte MC, Figueira GM, Sartoratto A, Rehder VL, Delarmelina C. Anti-Candida activity of Brazilian medicinal plants. Journal of ethnopharmacology.2005; 97(2):305-11.
9.Frey FM, Meyers R. Antibacterial activity of traditional medicinal plants used by Haudenosaunee peoples of New York State. BMC complementary and alternative medicine. 2010; 10: 64.
10.Gião, MS, González-Sanjosé, ML, Rivero-Pérez, M. D., Pereira, C. I.,Pintado, M. E. and Malcata, F. X. Infusions of Portuguese medicinal plants: Dependence of final antioxidant capacity and phenol content on extraction features. J. Sci. Food Agric. 2007; 87: 2638–2647. doi: 10.1002/jsfa.3023.
11.Golalipour, M., Khori, V., Ramin.Azarhoush, R., Nayebpour, M., & Azadbakh, M. (2004). Effect of Achillea Santolina on Mice Spermatogenesis. DARU Journal Of Pharmaceutical Sciences,12(1):36-39. 12.Holetz F B, Pessini G L, Sanches N R, Cortez D A G, Nakamura C V, Filho B P D.Screening of some plants used in the Brazilian Folk Medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2002;97:1027–1031.
13.Jonsdottir G, Omarsdottir S,Vikingsson A, Hardardottir I, Freysdottir J.Aqueous extracts from Menyanthes trifoliate and Achillea millefolium affect maturation of human dendritic cells and their activation of allogeneic CD4+ T cells in vitro. Journal of ethnopharmacology 2011;136 (1): 88-93.
14.Karamenderes C, Apaydin S. Antispasmodic effect of Achillea nobilis L.subsp.sipylea (O. Schwarz) Bassler on the rat isolated duodenum. Journal of ethnopharmacology 2003; 84(2-3):175-9.
15.Konyalioglu S, Karamenderes C. The protective effects of Achillea L. species native in Turkey against H (2)O(2)-induced oxidative damage in human erythrocytes and leucocytes. Journal of ethnopharmacology. 2005; 102(2):221-7.
16.Lans C, Turner N, Khan T, Brauer G,Boepple W.Ethnoveterinary medicines used for ruminants in British Columbia, Canada. Journal of ethnobiology and ethnomedicine 2007; 3: 11.
17.Murnigsih T, Subeki, Matsuura H,Takahashi K, Yamasaki M, Yamato O. Evaluation of the inhibitory activities of the extracts of Indonesian traditional medicinal plants against Plasmodium falciparum and Babesiagibsoni. The Journal of veterinary medical science / the Japanese Society of Veterinary Science 2011; 67 (8): 829-31.
18.Nilforoushzadeh MA, Shirani-Bidabadi L,Zolfaghari-Baghbaderani A, Saberi S,Siadat AH, Mahmoudi M. Comparison of Thymus vulgaris (Thyme), Achilleamillefolium (Yarrow) and propolishydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice. Journal of vector borne diseases 2008; 45 (4): 301-6.
19.Pires JM, Mendes FR, Negri G, Duarte-Almeida JM, Carlini EA. Antinociceptive peripheral effect of Achilleamillefolium L. and Artemisia vulgaris L.: both plants known popularly by brand names of analgesic drugs. Phytotherapy research.2008; PTR 23 (2): 212-9.
20.Potrich FB, Allemand A,da Silva LM, Dos Santos AC, Baggio CH, Freitas CS.Antiulcerogenic activity of hydroalcoholic extract of Achilleamillefolium L.: involvement of the antioxidant system. Journal of ethnopharmacology. 2010; 130 (1): 85-92.
21.Raudonis R, Jakstas V,Burdulis D, Benetis R, Janulis V. Investigation of contribution of individual constituents to antioxidant activity in herbal drugs using postcolumn HPLC method. Medicina. 2009;45 (5): 382-94.
22.Sant'Anna, J. R. d.,Franco, C.C. d. S.,Miyamoto, C. T., Cunico, M. M.,Miguel, O. G., Côcco, L. C., Yamamoto, C. I., Junior, C. C. and Castro-Prado, M. A. A. d. Genotoxicity of Achillea millefolium essential oil in diploid cells of Aspergillusnidulans. Phytother. Res 2009; 23: 231–235. doi: 10.1002/ptr.2596.
23.Stojanovic G, Radulovic N, Hashimoto T, Palic R. In vitro antimicrobial activity of extracts of four Achillea species: the composition of Achillea clavennae L. (Asteraceae) extract. Journal of ethnopharmacology 2005; 101 (1-3):185-90.
24.Tajik H, Jalali F, Sobhani A, Shahbazi Y, SoleimanZadeh M. In vitro assessment of antimicrobial efficiency of alcoholic extract of Achillea millefolium in comparison with Penicillin derivitives. J. Anim. Vet. Adv. 2008; (4): 508-511.
25.Tarnawski, A.S. Cellular and molecular mechanisms of gastrointestinal ulcer healing.Digestive Disease and Sciences. 2005;50:24–33.
26.Temamogullari, F., Hayat, A., & Baba, F. (2009). Effects of Yarrow Extract on Wound Healing in Rabbits. Journal of Animal and Veterinary Advances, 8(6), 1204-1206.
27.Petlevski R., Hadžija, M., Slijepčević, M., Juretić, D., & Petrik, J. Glutathione S‐transferases and malondialdehyde in the liver of NOD mice on short‐term treatment with plant mixture extract P‐9801091. Phytotherapy Research, 2003;17(4):311-314. 28.Pires, J. M., Mendes, F. R., Negri, G., Duarte‐Almeida, J. M., & Carlini, EA. Antinociceptive peripheral effect of Achillea millefolium L. and Artemisia vulgaris L.: both plants known popularly by brand names of analgesic drugs.Phytotherapy Research, 2009;23(2):212-219.
29.Lietava, J. Medicinal plants in a Middle Paleolithic grave Shanidar IV?.Journal of Ethnopharmacology, 1992; 35(3):263-266.
30.Heinrich M., Robles, M., West, J. E., Ortiz de Montellano, B. R., & Rodriguez, E. Ethnopharmacology of Mexican asteraceae (compositae). Annual Review of Pharmacology and Toxicology, 1998;38(1):539-565.
31.Gutiérrez-Venegas, G., Jiménez-Estrada, M., & Maldonado, S.The effect of flavonoids on transduction mechanisms in lipopolysaccharide-treated human gingival fibroblasts. International immunopharmacology, 2007; 7(9):1199-1210.
32.Ficarra R, Ficarra P, Tommasini S et al.. Leaf extracts of some Cordia species–analgesic and antiinflammatory activities as well as their chromatographic analysis. Farmaco. 1995;50: 245– 256.
33.Schulz V, Hänsel R, Tyler VE. 2001. Rational Phytotherapy: A Physician’s Guide to Herbal Medicine. Springer: Berlin; 294.
34.Mistieri MLA, Thomazo NMM, Mataqueiro MI, Queiroz-Neto A. Study of the analgesic properties of the Achillea millefolium. Rev Bras Plan Med. 2001;3: 1–6.
35.Ahmad F, Khan RA, Rashid S. Pharmacological evaluation of medicinal plants for their analgesic activity in mice. Med J Islam Repub Iran. 1996;10: 149–152.
36.Di Stasi LC, Hiruma-Lima CA. Plantas Medicinais na Amazôniae na Mata Atlântica. Editora Unesp: São Paulo, 2002: 464–466.
37.Guo Y. P., Saukel, J., Mittermayr, R., & Ehrendorfer, F. AFLP analyses demonstrate genetic divergence, hybridization, and multiple polyploidization in the evolution of Achillea (Asteraceae‐Anthemideae). New Phytologist,2005; 166(1), 273-290.
38.Ghasemi, Y, Khalaj, A, Mohagheghzadeh, A, & Khosaravi, A. Composition and in vitro antimicrobial activity of the essential oil of Achillea eriophora. Chemistry of natural compounds,2008; 44(5): 663-665.
39.Sezik, E., Yesilada, E., Shadidoyatov, H., Kulivey, Z., Nigmatullaev, AM, Aripov, HN, & Honda, G. (2004). Folk medicine in Uzbekistan: I. Toshkent, Djizzax, and Samarqand provinces. Journal of Ethnopharmacology, 92(2):197-207.
40.Dall`Acquaa S, Bolego C, Cignarella A, Gaion RM, Innocenti G. Vasoprotective activity of standardized Achillea millefolium extract. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2011;18(12):1031-6.
41.Javidnia, K., Miri, R., & Sadeghpour, H. Composition of the volatile oil of Achillea wilhelmsii C. Koch from Iran. DARU Journal of Pharmaceutical Sciences, 2004; 12(2):63-68.
42.Broudiscou L, Papon Y, Broudiscou A. Effects of dry plant extracts on feed degradation and the production of rumen microbial bi mass in a dual outflow fermenter. L.-P. Animal Feed Science and Technology. 2002;101:183–189.
43.Bocevska M, Sovova H. Supercritical CO2 extraction of essential oil from yarrow. J of Supercritical Fluids. 2007; 40:360–367.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Moloudizargari M,Aghajanshakeri S,Javaherypour Soheil,Escort M,Velzi Salar,Velzi Sina. This is an open access article distributed under the Creative Commons Attribution
Original article:
Abul Fazil MD1, Sheetal Raj M MD2, Aditya Verma MBBS3, Jagadish Rao Padubidri MD, DNB4,*
Affiliation:-
1Assistant Professor, Department of Medicine, 2Senior Resident, Department of Medicine, 3Undergraduate Medical Student,4Associate Professor, Department of Forensic Medicine, Kasturba Medical College, Mangalore,Karnataka, India [Affiliated to Manipal University]
The name of the department(s) and institution(s) to which the work should be attributed:
Department of Medicine, Kasturba Medical College, Mangalore, Karnataka, India [Affiliated to Manipal University].
*To whom it corresponds:-
Dr. Jagadish Rao Padubidri.
Associate Professor, Forensic Medicine and Toxicology, Kasturba Medical College, Light House Hill Road, Mangalore-1, Karnataka, India.[ Affiliated to Manipal University].
Contact No: +91-9900405085+91-9900405085.
Abstract
Background/ objective: Leptospirosis is a spirochetal bacterial infection of great public health importance. Acute pancreatitis is an uncommon gastrointestinal manifestation of leptospirosis. The aims and objective of this study was to find the incidence of hyperamylasemia in cases of severe leptospirosis and to correlate the incidence of hyperamylasemia with acute pancreatitis among patients with severe leptospirosis.
Methods: All patients who were positive for IgM ELISA test (IgM ELISA > 11 panbiounits was considered positive for leptospirosis) and had features suggestive of severe leptospirosis or Weil’s disease were included in the study. Serum amylase levels were assessed in all patients, included in the study. An ultrasound of the abdomen was done to objectively confirm or refute the presence of acute pancreatitis in all patients included in the study.
Results: The study included 25 cases diagnosed of Severe Leptospirosis. 24 out of 25 cases [96 %] had renal failure. All the cases [100%] had deranged liver function tests. 17 out of the 25 [68%] cases had hyperamylasemia. Almost all patients showed evidence of multi organ dysfunction in the form of deranged renal function or hepatic dysfunction or both. Out of the total 25 cases included in the study, 17 cases[68%] showed elevated levels of serum amylase.
Conclusions: It is evident from this study that despite of low reporting, the dangerous complication of acute pancreatitis is not so rare among patients with severe leptospirosis. Hyperamylasemia is commonly seen with an incidence of 68% among these patients. Our study shows that, threefold rise of serum amylase level remains a very specific and cost effective test for detection of acute pancreatitis in patients with severe leptospirosis.
Keywords: Leptospirosis; serum amylase; hyperamylasemia; acute pancreatitis.
REFERENCES
1.Smita B. Shekatkar, Belgode N. Harish, Godfred A. Menezes and Subhash C. Parija. Clinical and serological evaluation of leptospirosis in Puducherry, India . J Infect Dev Ctries. 2010; 4(3):139-143.
2.Susan S Philip, Spirochaetal Infections. In: Stephen J. McPhee, Maxine A Papadakis . editors Current Medical Diagnosis and Treatment 2011.50th edition.The McGraw Hill Companies,Inc;2011. Pg 1414.
3.Ekrem Kaya, Adem Dervisoglu, Cafer Eroglu, Cafer Polat, Mustafa Sunbul, Kayhan Ozkan . Acute pancreatitis caused by leptospirosis: report of two cases . World J Gastroenterol - 2005;11(28):4447-4449.
4.Anne Spichler, Ethel Spichler, Marcelo Moock, Joseph M. Vinetz and John A. D. Leake . Acute pancreatitis in fatal anicteric leptospirosis. Am J Trop Med Hyg. 2007 May;76(5): 886-887.
5.Philip p. Toskes , Norton J. Greenberger . Approach to the patient with pancreatic disease . In:Fauci , Braunwald ,Kasper, Hauser,Longo,Jameson,Loscalzo editors . Harrison’s principles of Internal Medicine. 17th ed .The McGraw Hill Companies ,Inc ; 2008 . pg 2001 -2005.
6.Yadav D, Agarwal N, Pitchumoni C.S. A critical evaluation of laboratory tests in acute pancreatitis.Am J Gastroenterol; 2002 Jun; 97(6):1309-18.
7.Edwards G A, Domm B M. Human leptospirosis. Medicine. 1960;39:117–156.
8.Kelley P. W. Leptospirosis. In: Gorbach S L, Bartlett J G, Blacklow N R, editors. Infectious diseases. 2nd ed. Philadelphia, Pa: W. B. Saunders; 1998. pp. 1580–1587.
9.Turner L H. Leptospirosis I. Trans R Soc Trop Med Hyg. 1967;61:842–855.
10.Paul N. Levett. Leptospirosis. Clinical Microbiology Reviews, Apr. 2001:296–326.
Doi:10.1128/Cmr.14.2.296–326.2001.
11.Heath C. W., Alexander A. D., Galton M. M. Leptospirosis in the United States: 1949–1961. N Engl J Med. 1965; 273:857–864. ,915–922.
12.Abdulkader R. C. R. M. Acute renal failure in leptospirosis. Renal Fail. 1997;.19:191–198.
13.Edwards C. N., Nicholson G. D., Hassell T. A., Everard C. O. R., Callender J. Leptospirosis in Barbados: a clinical study. West Indian Med J. 1990;39:27–34.
14.Ramachandran S., Rajapakse C. N. A., Perera M. V. F., Yoganathan M. Patterns of acute renal failure in leptospirosis. J Trop Med Hyg. 1976;79:158–160.
15.Winearls C. G., Chan L., Coghlan J. D., Ledingham J. G. G., Oliver D. O.. Acute renal failure due to leptospirosis: clinical features and outcome in six cases. Q J Med. 1984; 53:487–495.
16.Farr R.W. Leptospirosis. State-of-the-art article. CID 1995;21: 1-6.
17.Wang N.C., Ni Y.H.,Chanq F.Y. Acute acalculous cholecystitis and pancreatitis in a patient with concomitant leptospirosis and scrub typhus. J Microbiol and Immunol and Infect. 2003; 36(4);285- 287.
18.Brien M.M., Vincent J.M., Person D.A.,Cook B.A., Leptospirosis and Pancreatitis- Report of 10 Cases. J Ped Infect Dis 1998; 17(5); 436-438.
19.Thunga G. , Mallayasamy S.R. ,Mangasuli S.,Bhat R. A case report of Leptospirosis induced Acute pancreatitis. Journal of Clinical and Diagnostic Research [serial online] 2008 october[cited: 2008 october 6]; 2:1100-1102.
20.Yang R.W., Shao Z.X., Chen Y.Y., Yin Z., Wang W.J. Lipase and pancreatic amylase activities in diagnosis of acute pancreatitis in patients with hyperamylasemia.Hepatobiliary Pancreat Dis Int. 2005 Nov;4(4):600- 603.
21.Domènech Calvet J., Sánchez Cano J.J., Sánchez Marín A., Sánchez Pérez J., Guspí Saiz F, Bertran Llusà N, del Castillo Déjardin D., Macroamylasemia in the differential diagnosis of acute pancreatitis. Revista Clinica Espanola. 1999 Jul;199(7):440-441
22.Edwards C.N., Evarard C.O.R.. Hyperamylasemia and pancreatitis in leptospirosis. Am J Gastroenterol 1991; 86:1665–1668.
23.Kameya S, Hayakawa T, Kemaye A, Wtarabe T. Hyperamylasemia in patients at an intensive care unit. J Clin Gastroenterol 1986;8: 438-442.
24.Cengiz K, Sahan C, Sunbul M, Leblebicioglu H, Cuner E. Acute renal failure in leptospirosis in the black- sea region in Turkey. Int Urol Nephrol 2002;33: 133–136.
25.Isogai M, Yamagychi A, Nakano S. Hepatic histopathological changes in biliary pancreatitis. Am J Gastroenterol 1995;90: 449-454.
26.P Baburaj, T Antony, Francy Louis, BL Harikrishnan. Acute abdomen due to acute pancreatitis- a rare presentation of leptospirosis. J Assoc physicians India. 2008 Nov;56:911-912.
This research work was presented in the 45th APACPH conference 2013, which was held from 24th to 27th October 2013, at Wuhan University, Wuhan, China.
Article citation:
Abul Fazil, Sheetal Ra M, Aditya Verma, Jagadish Rao Padubidri. Hyperamylasemia as an indicator of Acute Pancreatitis in Severe Leptospirosis- A preliminary study. J Pharm Biomed Sci 2014; 04(04):273-278. Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Abul Fazil, Sheetal Raj M, Aditya Verma, Jagadish Rao Padubidri. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Original article:
Badyal Ashima1,*, Pandey Rajesh2, Sodhi KS2, Singh Jasbir4.
Affiliation:-
1Registrar, Department of Biochemistry, GMC, Jammu, J&K, India
2Professor,3Professor and Head, Department of Biochemistry, MMIMSR, Mullana, Ambala, Haryana, India
The name of the department(s) and institution(s) to which the work should be attributed:
1. Department of Biochemistry, GMC, Jammu, J&K, India
2. Department of Biochemistry, MMIMSR, Mullana, Ambala, Haryana, India
*To whom it corresponds:-
Dr. Ashima Badyal.
214-A Shastri Nagar, Jammu, J&K State, India- 180004
Contact no: +91-9796825414+91-9796825414 .
Abstract:
Context: Controversial reports are available regarding the status of magnesium on glycemic control in type 2 diabetes mellitus. Serum magnesium levels are not investigated in routine practice despite its significance. Aims: The present study was designed to compare the serum magnesium of type 2 diabetic patients without complications with those of non diabetic controls and to assess the relationship between these two. Setting and Design: Prospective cross sectional study in rural setting of Haryana. Materials and Methods: 50 healthy controls and 100 patients with type 2 diabetes mellitus without complications were recruited from Medicine OPD of MMIMSR, Mullana, Ambala (Haryana), and their serum glucose and serum magnesium levels were measured and compared. Statistical Analysis: By SPSS version 12 [SPSS v12 (SPSS Inc., Chicago, IL)]. Results: The serum magnesium levels were significantly lower in diabetic subjects. Conclusions: Serum magnesium status needs to be routinely checked in diabetic patients and, if reduced, need to be appropriately corrected.
Keywords: Complications; diabetes mellitus; glucose; magnesium.
REFERENCES
1.Parizadeh SM, Faal G, Valaee L. Maternal serum magnesium level and low birth Weight neonate. Int J Prev Med 2013; 4(12): 1476–79.
2.Zimet P, Albert KG, Shaw J. Global and societal implications of diabetes epidemic. Nature 2001; 414: 782-87.
3.Nair P, Christensen MS, Christensen C, Masbad S, Transbol I. Renal hypomagnesemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest 1982; 12; 81-5.
4.Geiger H, Wanner C. Magnesium in disease. Clin Kidney J 2012; 5(1) 26-38.
5.Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007; 2: 366–73.
6.Dayanand CD, Krishamurthy N, Kiran S, Naveen. Evaluation of biochemical parameters evincing atherogenic potency in type 2 diabetic retinopathy. Int J Biol Med Res 2011; 2 (2):539-42.
7.Hans CP, Sialy R, Bansal DD. Magnesium deficiency and diabetes mellitus. Curr Sci 2002;83(12): 1456-63.
8.Paolisso G, Barbagallo M. Hypertension, diabetes mellitus and insulin resistance. The role of intracellular magnesium. Am J Hypertens 1997; 10 (3): 346-55.
9.Powers CA. Diabetes mellitus. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo BL,Jameson JL, editors. Harrison’s principles of internal medicine, 17th edition. United States of America (New York): Mc Graw Hill Company, Inc; 2008, p. 2275-2304.
10.Basak A. Development of a rapid and inexpensive plasma glucose estimation by two point kinetics method based on glucose–oxidase-peroxidase enzymes. Indian J Clin Biochem 2007; 22(1): 156-60.
11.Barbour HM, Davidson W. Studies on measurement of plasma magnesium: application of magnon dye method to the “monarch” centrifugal analyzer. Clin Chem 1988; 34: 2103-5.
12.Cockram C, Chan J. The epidemiology of diabetes in the Western Pacific Region (excluding Japan). In: Turle J, Kaneko T, Osato S, Eds. Diabetes in the New Millennium. Sydney, Pot Still Press, 1999, p. 11–22.
13.Wilson WF, Anderson M, Kannel B. Epidemiology of diabetes mellitus in the elderly the Framingham study. Am J Med 1986; 80(5): 3-9.
14.Nakagami T, Qiao Q, Tuomilehto J, Ballau B, Cartensen B, Tajima N, et al. The fasting plasma glucose cut-point predicting a diabetic 2hr OGTT glucose level depends on the phenotype.Diabetes Res Clin Pract 2002; 55: 35-43.
15.Mane M, Chaudhary RG, Reddy PE. Hypomagnesemia in diabetic patient and biochemical action on cardiovascular system. Int J Biol Med Res 2012; 3(1): 1273-76.
16.Earle C, Heshka S, Gallagher D, Wang J, Sunyer X, Richard N. Serum magnesium and type 2 diabetes in African Americans and Hispanics: a new cohort study. Am J Clin Nutr 2006;25(6): 509-13.
17.Mooren FC, Kruger K, Volker F, Golf SW, Wadepuhi M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non diabetic subjects- a double blind, placebocontrolled, randomized trial. Diabetes Obes Metab 2011; 13(3):281-4.
Article citation:
Badyal Ashima,Pandey Rajesh,Sodhi KS,Singh Jasbir. Decreased Serum Magnesium in Patients with Uncomplicated Type 2 Diabetes Mellitus. J Pharm Biomed Sci. 2014;04(04):361-364.Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Research article:
Idoko J1,*, Enemari JO1, Okolo SC1, Yaro DJ1, Akpulu, P2, Mairiga AA1, Aghenumu L1, Owolagba G1, Dasi KR3,Anyebe EE4 , Ameh EA5, Ogboi SJ3
Affiliation:-
1Department of Pathology Ahmadu Bello University Teaching Hospital Zaria
2Department of Human Anatomy Ahmadu Bello University Zaria
3Research and Training Unit, Department of Nurse Education, ABU Teaching Hospital Zaria.
4Paediatric Surgery Unit, Department of Surgery, A.B.U. Teaching Hospital Zaria, Nigeria
5Public Health Lab. Department of Med. comm. ABU Zaria
The name of the department(s) and institution(s) to which the work should be attributed:
1.Department of Pathology Ahmadu Bello University Teaching Hospital Zaria.
2.Department of Human Anatomy Ahmadu Bello University Zaria.
3.Research and Training Unit, Department of Nurse Education, ABU Teaching Hospital Zaria.
4.Paediatric Surgery Unit, Department of Surgery, A.B.U. Teaching Hospital Zaria, Nigeria
5.Public Health Lab. Dept of Med. comm. ABU Zaria.
*To whom it corresponds:-
Idoko J.
Department of Pathology Ahmadu Bello University Teaching Hospital Zaria.
Contact number:- +2348061397320+2348061397320
Abstract:
High incidence of death has been associated with cervical cancer in the developing countries in the recent times, and so it is imperative to advance its detection. Hairspray (NOVA) was compared with routine 95% ethanol to assess the efficiency in cyto diagnosis of cervical smear. Two hundred (200) cervical smeared samples in duplicate were collected from patients, carefully labeled and were fixed immediately, using routine 95% ethanol and with hairspray (Nova) respectively. The slides were stained by papanicolaou technique and were evaluated. There was no degeneration of cell morphology and no significant toxic effect of the Hairspray (NOVA) when compared with 95% alcohol. The cells appeared normal, without shrinkage and with a clear background and good nuclear outline. Hairspray (NOVA) is cost effective, efficient, handy and easy to use. It is shown that, hairspray (Nova) is effective for cervical smear.
Keywords: Hairspray; routine fixative; cervical smear.
REFERENCES
1.Baharom Anisah, Ismail Maimunah. Case Studies on Decision for Cervical Cancer Screening among Working Women The Journal of Human Resource and Adult Learning,2008:4(2):173-183.
2.Bancroft J D and Stevens (2010) Theory and Practice of Histopathological Techniques 3rd ed P 466. Churchhill Livingstone London, New York.
3.Freeman, J. A. (1969): Fixation of smears using cytofixative Acta Cytol.(philad.),13,416.
4.Innovatek Medical Inc. ( 2003) #3- 1600 Derwent way, Delta Canada. V3MS6M5.
5.Kumar, Vinar; Abbas, Abul k, Fausto, Nelson; Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.) sauders Elsevier. London.
6.Kumarasinghe M P, Constantine T S R, Hemarnali T R LC. Methanol as an alternative fixative for cytological smears, Malaysian J Patlzol,1997;19(2): 137 – 140.
7.Lim G.C.C. Halimah Y. (2004) Second Report of the National Cancer Registry. Cancer Incidence in Malaysia 2003. National Cancer Registrt. Kuala Lumpur.
8.Markovic, M., Kesic V., Topic L., Matejic, B. Barriers to cervical cancer screening: a qualitative study with women in Serbia. Social science and medicine,2005; 61:2528-2535.
9.Ramzi SC Stanley RL, Vinary K (1999) Disease of The Female Genital Tract in pathologic basis of disease 6th ed. Published by Saunders philadephia London Toronto Mexico city.
10.Shamsi M, Abdali K, Montazer NR, Kumar PV, Tabatabaee HR. Comparison of Carnoy's solution and 96% ethyl alcohol fixation in bloody Pap smears.Acta Cytol. 2003;47(4):630-6.
11.Utian, Wulf H. Hairspray as an Inexpensive Fixative for Papanicolaou Smears South Africa medical journal , 1972;46 835-837.
Article citation:
Idoko J, Enemari JO, Okolo SC, Yaro DJ, Akpulu P, Mairiga AA et al. Hairspray (NOVA) as a substitute for Routine fixatives in cervical smear. J Pharm Biomed Sci 2014; 04(04): 327-331. Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Idoko J, Enemari JO, Okolo SC, Yaro DJ, Akpulu P, Mairiga AA et al. . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Case report:
Banushree C Srinivasamurthy MD DNB, Ambedkar Raj Kulandaivelu MD
Affiliation:-
1Assistant Professor, Department of Pathology & Lab Medicine, AIIMS, Bhubaneswar, India
2Associate Professor, Department of Pathology, Sri Manakula Vinayagar Medical College, Puducherry, India
The name of the department(s) and institution(s) to which the work should be attributed:
1. Department of Pathology & Lab Medicine, AIIMS, Bhubaneswar, India
2. Department of Pathology, Sri Manakula Vinayagar Medical College, Puducherry, India
*To whom it corresponds:-
Dr Banushree CS.
Assistant Professor, Department of Pathology & Lab Medicine, AIIMS, Bhubaneswar, India
Contact no:-+91- 9438884174+91- 9438884174
Abstract
The most common cause of malignant ascites in women is intraperitoneal spread from an ovarian primary carcinoma, usually of the papillary serous type. Occasionally, women with serous borderline tumors present with ascites. Papillary serous neoplasms of the ovary and peritoneum need to be recognized in cytology specimens for appropriate diagnosis and/or staging purposes. Borderline serous carcinoma can go undetectable in intra-operative exploration alone, so cytological examination of peritoneal washings should be done. The distinction of reactive mesothelial cells from serous neoplasms in peritoneal fluids is possible in most patients by cell group architecture and cytological features. We encountered a rare case of borderline papillary serous carcinoma of ovary with presence of malignant cells in peritoneal washing in a forty-three year old female which helped in predicting the behavior and staging of the tumour and establishing proper line of management.
Keywords: Peritoneal washing; reactive mesothelial cells; papillary serous neoplasms; ovary.
REFERENCES
1.P. Tauchi S, N. Caraway, L. D. Truong, A. L. Kaplan, and I. Ramzy. Serous surface carcinoma of the peritoneum: useful role of cytology in differential diagnosis and follow-up. Acta Cytol. 1996. 40:429–436.
2.Lee, A, Z. W. Baloch, G. Yu, and P. K. Gupta. Mesothelial hyperplasia with reactive atypia: diagnostic pitfalls and role of immunohistochemical studies—a case report. Diagn Cytopathol. 2000. 22:113–116.
3.Zuna, R. E, M. L. Mitchell , K. A. Mulick , and W. M. Weijchert . Cytohistologic correlation of peritoneal washing cytology in gynecologic disease. Acta Cytol. 1989. 33:327–336.
4.Ziselman, E. M. , S. E. Harkavy , M. Hogan , W. West , and B. Atkinson . Peritoneal washing cytology: uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol 1984;28:105–110.
5.Covell JL, Carry JB, Feldman PS. Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis. Acta Cytol. 1985;29:310–6.
6.Ravinsky E. Cytology of peritoneal washings in gynecologic patients. Diagnostic criteria and pitfalls. Acta Cytol.1986;30:8–16.
7.Gurley AM, Hidvegi DF, Cajulis RS, Bacus S. Morphologic and morphometric features of low grade serous tumours of the ovary. Diagn Cytopathol.1994; 11:220–5.
8.Mulvany N. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids. Acta Cytol 1996;40:1231–9.
9.Johnson TL, Kumar NB, Hopkins M, Hughes JD. Cytologic features of ovarian tumors of low malignant potential in peritoneal fluids. Acta Cytol1988; 32:513–8.
10.Oscar Lin. Challenges in the Interpretation of Peritoneal Cytologic Specimens. Arch Pathol Lab Med. 2009; 133:739-742.
Article citation:
Banushree C Srinivasamurthy, Ambedkar Raj Kulandaivelu. Cytologic identification of borderline papillary serous carcinoma of ovary in peritoneal washing cytology:a case report and review of literature. J Pharm Biomed Sci. 2014; 04(04):279-283. Available at www.jpbms.info.
Source of support: None
Competing interest / Conflict of interest
The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Copyright © 2014 Banushree C Srinivasamurthy, Ambedkar Raj Kulandaivelu.This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.